Japanese Healthtech Stock News

TSE:3106
TSE:3106Luxury

Nanjing Develop Advanced Manufacturing Leads 3 Undiscovered Gems in Asia

As global markets grapple with rising inflation and geopolitical uncertainties, the Asian market continues to present unique opportunities for investors, particularly in the small-cap sector. In this dynamic environment, identifying stocks with strong fundamentals and growth potential can be key to navigating these challenges; Nanjing Develop Advanced Manufacturing is one such company leading a trio of undiscovered gems in Asia.
TSE:4516
TSE:4516Pharmaceuticals

Should Lawsuit Over Deramiocel Deal and Gazyva Expansion Efforts Require Action From Nippon Shinyaku (TSE:4516) Investors?

Earlier this month, Capricor Therapeutics filed a lawsuit in New Jersey seeking to unwind its U.S. distribution deal with Nippon Shinyaku’s subsidiary over alleged pricing flaws and launch-preparation failures for Duchenne muscular dystrophy therapy Deramiocel, while Nippon Shinyaku also reported revenue growth, softer profit and an unchanged dividend for the year to March 2026. Ahead of its forecast for higher earnings in fiscal 2027, Nippon Shinyaku and Chugai applied in Japan to expand...
TSE:4151
TSE:4151Pharmaceuticals

Is Kyowa Kirin (TSE:4151) Pricing Reflect Its Mixed Long Term Share Performance

If you are wondering whether Kyowa Kirin is attractively priced or not, the starting point is to understand what the current share price actually reflects about the business. Over the last week the stock is up 1.9%, although it is down 3.9% over the past month and down 5.7% year to date, while the 1 year return stands at 9.9% and the 5 year return shows a 22.0% decline. Recent coverage around Kyowa Kirin has focused on how investors interpret its long term prospects and the balance between...
TSE:4307
TSE:4307IT

Nomura Research Institute Dividend Hike Tests Balance Between Income And Growth

Nomura Research Institute (TSE:4307) has announced a significant full year dividend increase. The company reaffirmed its commitment to stable shareholder returns, maintaining its payout policy. Management highlighted strong domestic business performance, while acknowledging recent impairment charges. For investors watching Nomura Research Institute at a share price of ¥4,332.0, the larger dividend stands out against a mixed return profile. The stock is down 11.1% over the past month and...
TSE:4755
TSE:4755Multiline Retail

Rakuten Group (TSE:4755) Valuation After Q1 2026 Sales Growth And Narrower Net Loss

Rakuten Group (TSE:4755) is back in focus after reporting first quarter 2026 results, with sales of ¥643,583 million and a net loss of ¥18,648 million, both changing meaningfully compared with a year earlier. See our latest analysis for Rakuten Group. The latest earnings release appears to have shifted sentiment, with the 1-day share price return of 2.34% and 7-day share price return of 4.06% contrasting with a year-to-date share price decline of 22.48% and a 3-year total shareholder return...
TSE:285A
TSE:285ASemiconductor

Kioxia Holdings (TSE:285A) Q3 EPS Surge To ¥162 Challenges Bearish Earnings Narratives

Kioxia Holdings (TSE:285A) has reported another strong quarter for FY 2026, with Q3 revenue of ¥543,631 million and basic EPS of ¥162.13, as investors weigh these figures against a current share price of ¥44,450. The company’s quarterly revenue moved from ¥347,094 million in Q4 FY 2025 to ¥342,799 million in Q1 FY 2026, then ¥448,346 million in Q2 and ¥543,631 million in Q3. Over the same period, basic EPS shifted from ¥37.61 to ¥33.90, then ¥75.36 and ¥162.13, giving a clear view of how the...